DIAGNOS Announces Amendment to Its Stock Option Plan

DIAGNOS Announces Amendment to Its Stock Option Plan

ID: 177187

(firmenpresse) - BROSSARD, QUEBEC, CANADA -- (Marketwire) -- 08/23/12 -- DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces that the board of directors of the Corporation has approved an amendment to the Corporation's stock option plan in order to increase the maximum number of common shares that may be issued pursuant thereto from 8,000,000 to 12,000,000. This amendment is subject to TSX Venture acceptance and shareholders' approval.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE: ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Andre Larente, President
DIAGNOS inc.
450-678-8882


Louis Morin
Bid Capital Markets
514-845-1101



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  ScreenRetriever Offers Back-to-School Help for Homework, Online Safety KANA Enterprise Agent Desktop Named KMWorld Trend-Setting Product of 2012
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 23.08.2012 - 14:21 Uhr
Sprache: Deutsch
News-ID 177187
Anzahl Zeichen: 6858

contact information:
Town:

BROSSARD, QUEBEC, CANADA



Kategorie:

Software



Diese Pressemitteilung wurde bisher 187 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"DIAGNOS Announces Amendment to Its Stock Option Plan"
steht unter der journalistisch-redaktionellen Verantwortung von

Diagnos Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

DIAGNOS Closes Second Tranche of Private Placement ...

BROSSARD, QUEBEC -- (Marketwired) -- 10/23/17 -- DIAGNOS Inc. ("DIAGNOS" or the "Corporation") (TSX VENTURE: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence, ...

Alle Meldungen von Diagnos Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z